Company news

Innoviva, Inc. news in 2026

Innoviva, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Innoviva Reports Third Quarter 2026 Financial Results; Highlights Recent Company Progress

November 4, 2026

Innoviva Specialty Therapeutics to Present Data Across Infectious Disease Portfolio at IDWeek 2026

October 19, 2026

Innoviva Specialty Therapeutics' Antimicrobial Therapies, XACDURO(R), ZEVTERA(R) and NUZOLVENCE(R) Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award

August 12, 2026

Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award

August 11, 2026

Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress

August 5, 2026

Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy’s for XACDURO® in Select International Markets

June 16, 2026

Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress

May 6, 2026

Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation’s 2026 Antimicrobial Resistance Benchmark Report

March 10, 2026

Innoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Progress

February 24, 2026

Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 19, 2026

Decks in 2026